.png)
.png)
.png)
Upload Prescription
.png)
1 Strip = 10 Tablets
Aristopharma LtdProduct Description
Gliclazide is a second-generation sulfonylurea oral hypoglycemic agent widely used in the management of type 2 diabetes mellitus. It primarily functions by stimulating insulin secretion from the pancreatic beta cells; specifically, it binds to the sulfonylurea receptors (SUR1) on the ATP-sensitive potassium channels, causing them to close, which triggers calcium influx and subsequent exocytosis of insulin granules. What distinguishes gliclazide from other sulfonylureas is its relative selectivity for pancreatic receptors over cardiac receptors, alongside potential antioxidant properties and hemovascular effects, such as reducing platelet aggregation. It is characterized by its ability to provide effective glycemic control with a lower risk of severe hypoglycemia and weight gain compared to older agents in its class. Pharmacologically, it is often available in modified-release formulations that allow for once-daily dosing, improving patient adherence while maintaining stable plasma concentrations. However, its use requires caution in patients with significant renal or hepatic impairment, and it is generally contraindicated in type 1 diabetes where beta-cell function is absent.
Similar Products
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
Previously Browsed Items
.jpg)
.jpg)
.png)
.jpg)
.jpg)
.jpg)
.jpg)
Copyright ﾃつｩ 2026 | Saf1 Rx | All rights reserved
.jpg)
.jpg)
